Ampio Pharmaceuticals, Inc.
AMPEDelisted Apr 4, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001411906
Ampio Pharmaceuticals, Inc. was delisted on Apr 4, 2024; its insiders filed their last Form 4 on Jun 13, 2023; 28 institutions reported holding it in 13F filings for Q1 2024, worth $34.2K in total; no superinvestor held it.
Holders of 5% or more of AMPE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Ampio Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Ampio Pharmaceuticals, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Ampio Pharmaceuticals, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Dec 7, 2023 | Terker Bruce E | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2023 | Terker Bruce E | 13G/AOld format | – | – | – | SEC |
| Jul 8, 20224:57 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Apr 29, 2022 | Terker Bruce E | 13G/AOld format | – | – | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Jan 20, 2021 | Terker Bruce E | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Ampio Pharmaceuticals, Inc. shares.
No Form 144 notices for Ampio Pharmaceuticals, Inc. are on file.